Industry sources estimate up to 80% of clinical trials suffer delays of two to six months with entire drug development and market launch programs being set back fom one to four years. Not achieving R&D timetables coupled with delays in market introductions translates into increased development costs and lost profit opportunities that often total hundreds of millions of dollars. Unrealistic research protocol design, insufficient/slower than forecast patient recruitment, patient retention problems, research personnel turnover and communications issues are only a few of the reasons clinical trials can get off track.

Work with a collaboration that provides technical trial expertise and proven R&D process/metrics capabilities. We provide the technical expertise needed for effective trials design and simultaneously work with your team to establish efficient and trackable processes to improve implementation efficiency.